Drugs that contain Edoxaban Tosylate

1. Drug name - SAVAYSA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7365205 DAIICHI SANKYO INC Diamine derivatives
Apr, 2027

(4 years from now)

CN1894238A DAIICHI SANKYO INC Diamine Derivatives
Oct, 2012

(10 years ago)

CN100545160C DAIICHI SANKYO INC Diamine Derivatives
Oct, 2012

(10 years ago)

CN1826333B DAIICHI SANKYO INC Diamine Derivatives
Mar, 2022

(6 months ago)

CN1826333A DAIICHI SANKYO INC Diamine Derivatives
Mar, 2022

(6 months ago)

EP1415992A4 DAIICHI SANKYO INC Diamine Derivatives
Aug, 2022

(a month ago)

EP1415992A1 DAIICHI SANKYO INC Diamine Derivatives
Aug, 2022

(a month ago)

EP1415992B1 DAIICHI SANKYO INC Diamine Derivatives
Aug, 2022

(a month ago)

EP1405852B9 DAIICHI SANKYO INC Diamine Derivatives
Jun, 2027

(4 years from now)

EP1405852B1 DAIICHI SANKYO INC Diamine Derivatives
Jun, 2027

(4 years from now)

EP1405852A4 DAIICHI SANKYO INC Diamine Derivatives
Jun, 2027

(4 years from now)

EP1405852A1 DAIICHI SANKYO INC Diamine Derivatives
Jun, 2027

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9149532 DAIICHI SANKYO INC Pharmaceutical composition Mar, 2028

(5 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 15MG BASE TABLET;ORAL Prescription
EQ 30MG BASE TABLET;ORAL Prescription
EQ 60MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.